Skip to main content
Top
Gepubliceerd in: Quality of Life Research 8/2019

01-04-2019

The impact of progressive chronic kidney disease on health-related quality-of-life: a 12-year community cohort study

Auteurs: Melanie L. R. Wyld, Rachael L. Morton, Phil Clayton, Muh Geot Wong, Meg Jardine, Kevan Polkinghorne, Steve Chadban

Gepubliceerd in: Quality of Life Research | Uitgave 8/2019

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Quality-of-life is poor in end-stage kidney disease; however, the relationships between earlier stages of chronic kidney disease (CKD) and are poorly understood. This study explored longitudinal quality-of-life changes in a community-based CKD cohort and assessed associations between CKD and quality-of-life over time, and between baseline quality-of-life and CKD outcomes.

Methods

We used the Australian diabetes, obesity and lifestyle study—a nationally representative, prospective cohort with data collected at baseline, year 5 and year 12—to examine the relationships between CKD stage, quality-of-life and outcomes. Linear mixed regression, cox proportional hazards, Kaplan–Meier and competing risks analyses were used.

Results

Of 1112 participants with CKD and baseline quality-of-life data, the physical component summary (PCS) score was significantly lower than for the general population (p = 0.01 age and sex adjusted), while the mental component summary (MCS) score was no different (p = 0.9 age and sex adjusted). In our unadjusted mixed effects model, more advanced kidney disease was associated with lower PCS and higher MCS at baseline (p < 0.001 and p < 0.01, respectively); however, this effect was no longer significant after adjustment for demographic and clinical variables. The rate of decline in PCS over the period of follow-up was greatest for those with more advanced kidney disease (p < 0.001 in unadjusted model, p = 0.007 in adjusted model). There was no association between change in MCS over the period of follow-up and severity of kidney disease in either the unadjusted or adjusted model (p = 0.7 and p = 0.1, respectively). Lower PCS, but not MCS, was associated with increased cardiovascular and increased all-cause mortality even after adjustment for key demographic and clinical variables (p < 0.001).

Conclusions

Physical, but not mental, quality-of-life is significantly impaired in CKD, and continues to decline with disease progression.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
3.
go back to reference Sanson-Fisher, R., & Perkins, J. (1998). Adaptation and validation of the SF-36 Health Survey for use in Australia. Journal of Clinical Epidemiology, 51, 961–967.CrossRef Sanson-Fisher, R., & Perkins, J. (1998). Adaptation and validation of the SF-36 Health Survey for use in Australia. Journal of Clinical Epidemiology, 51, 961–967.CrossRef
4.
go back to reference Dunstan, D. W., Zimmet, P. Z., Welborn, T. A., Cameron, A. J., Shaw, J., de Courten, M., et al. (2002). The Australian diabetes, obesity and lifestyle study (AusDiab)--methods and response rates. Diabetes Research and Clinical Practice, 57(2), 119–129.CrossRef Dunstan, D. W., Zimmet, P. Z., Welborn, T. A., Cameron, A. J., Shaw, J., de Courten, M., et al. (2002). The Australian diabetes, obesity and lifestyle study (AusDiab)--methods and response rates. Diabetes Research and Clinical Practice, 57(2), 119–129.CrossRef
6.
go back to reference White, S., Polkinghorne, K., Atkins, R., & Chadban, S. (2010). Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. American Journal of Kidney Diseases, 55(4), 660–670.CrossRef White, S., Polkinghorne, K., Atkins, R., & Chadban, S. (2010). Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. American Journal of Kidney Diseases, 55(4), 660–670.CrossRef
8.
go back to reference Ryan, P. (1999). SF36: Stata module to calculate summary statistics for the SF-36 Health Survey Instrument. Statistical Software Components. Boston College Department of Economics. Ryan, P. (1999). SF36: Stata module to calculate summary statistics for the SF-36 Health Survey Instrument. Statistical Software Components. Boston College Department of Economics.
9.
go back to reference Samsa, G., Edelman, D., Rothman, M. L., Williams, G. R., Lipscomb, J., & Matchar, D. (1999). Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics, 15(2), 141–155.CrossRef Samsa, G., Edelman, D., Rothman, M. L., Williams, G. R., Lipscomb, J., & Matchar, D. (1999). Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics, 15(2), 141–155.CrossRef
12.
go back to reference Drummond, M., Sculpher, M., Torrance, G., O’Brien, M., & Stoddart, G. (2005). Methods for the economic evaluation of health care programmes (3rd ed.). Oxford: Oxford University Press. Drummond, M., Sculpher, M., Torrance, G., O’Brien, M., & Stoddart, G. (2005). Methods for the economic evaluation of health care programmes (3rd ed.). Oxford: Oxford University Press.
13.
go back to reference Norman, R., Viney, R., Brazier, J., Burgess, L., Cronin, P., King, M., et al. (2014). Valuing SF-6D health states using a discrete choice experiment. Medical Decision Making, 34, 773–786.CrossRef Norman, R., Viney, R., Brazier, J., Burgess, L., Cronin, P., King, M., et al. (2014). Valuing SF-6D health states using a discrete choice experiment. Medical Decision Making, 34, 773–786.CrossRef
15.
go back to reference Magliano, D., Barr, E., Zimmet, P., Cameron, A., Dunstan, D., Colagiuri, S., et al. (2008). Glucose indices, health behaviours and the incidence of diabetes in Australia: The Australian diabetes, obesity and lifestyle study (AusDiab). Diabetes Care, 31, 267–272.CrossRef Magliano, D., Barr, E., Zimmet, P., Cameron, A., Dunstan, D., Colagiuri, S., et al. (2008). Glucose indices, health behaviours and the incidence of diabetes in Australia: The Australian diabetes, obesity and lifestyle study (AusDiab). Diabetes Care, 31, 267–272.CrossRef
16.
go back to reference World Health Organisation (2000). Obesity: preventing and managing the global epidemic, Report of a WHO Consultation (WHO Technical Report Series 894). World Health Organisation (2000). Obesity: preventing and managing the global epidemic, Report of a WHO Consultation (WHO Technical Report Series 894).
17.
go back to reference Commonwealth Department of Health and Aged Care. (1999). National physical activity guidelines for adults. Canberra: Active Australia. Commonwealth Department of Health and Aged Care. (1999). National physical activity guidelines for adults. Canberra: Active Australia.
18.
19.
go back to reference Magliano, D., Liew, D., Pater, H., Kirby, A., Hunt, D., Simes, J., et al. (2003). Accuracy of the Australian national death index: comparison with adjudicated fatal outcomes among Australian participants in the long-term intervention with pravastatin in ischaemic disease (LIPID) study. Australian and New Zealand Journal of Public Health, 27(6), 649–653. https://doi.org/10.1111/j.1467-842X.2003.tb00615.x.CrossRefPubMed Magliano, D., Liew, D., Pater, H., Kirby, A., Hunt, D., Simes, J., et al. (2003). Accuracy of the Australian national death index: comparison with adjudicated fatal outcomes among Australian participants in the long-term intervention with pravastatin in ischaemic disease (LIPID) study. Australian and New Zealand Journal of Public Health, 27(6), 649–653. https://​doi.​org/​10.​1111/​j.​1467-842X.​2003.​tb00615.​x.CrossRefPubMed
20.
go back to reference von Elm, E., Altman, D., Egger, M., Pocock, S., Gøtzsche, P., Vandenbroucke, J., et al. (2007). The Strengthening the reporting of observational studies in epidemiology (STROBE)statement: Guidelines for reporting observational studies. PLoS Medicine. 4(10), e296.CrossRef von Elm, E., Altman, D., Egger, M., Pocock, S., Gøtzsche, P., Vandenbroucke, J., et al. (2007). The Strengthening the reporting of observational studies in epidemiology (STROBE)statement: Guidelines for reporting observational studies. PLoS Medicine. 4(10), e296.CrossRef
21.
go back to reference Mckenzie, S. F. G., Richardson, K., & Carter, K. (2014). Do changes in socioeconomic factors lead to changes in mental health? Findings from three waves of a population based panel study. Journal of Epidemiology and Community Health, 68, 253–260.CrossRef Mckenzie, S. F. G., Richardson, K., & Carter, K. (2014). Do changes in socioeconomic factors lead to changes in mental health? Findings from three waves of a population based panel study. Journal of Epidemiology and Community Health, 68, 253–260.CrossRef
22.
go back to reference Williams, J., Cunich, M., & Byles, J. (2013). The impact of socioeconomic status on changes in the general and mental health of women over time: Evidence from a longitudinal study of Australian women. International Journal for Equity in Health, 12, 25.CrossRef Williams, J., Cunich, M., & Byles, J. (2013). The impact of socioeconomic status on changes in the general and mental health of women over time: Evidence from a longitudinal study of Australian women. International Journal for Equity in Health, 12, 25.CrossRef
23.
go back to reference Chadban, S., Briganti, E., Kerr, P., Dunstan, D., Welborn, T., Zimmet, P., et al. (2003). Prevalence of kidney damage in Australian adults: The AusDiab kidney study. Journal of the American Society of Nephrology, 14(Suppl 2), S131–S138.CrossRef Chadban, S., Briganti, E., Kerr, P., Dunstan, D., Welborn, T., Zimmet, P., et al. (2003). Prevalence of kidney damage in Australian adults: The AusDiab kidney study. Journal of the American Society of Nephrology, 14(Suppl 2), S131–S138.CrossRef
24.
go back to reference Wong, M., Ninomiya, T., Liyanage, T., Sukkar, L., Hirakawa, Y., Wang, Y., et al. (2018). Physical component quality of life (QOL) reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 QOL: An AUSDiab analysis. Nephrology, https://doi.org/10.1111/nep.13445.CrossRefPubMed Wong, M., Ninomiya, T., Liyanage, T., Sukkar, L., Hirakawa, Y., Wang, Y., et al. (2018). Physical component quality of life (QOL) reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 QOL: An AUSDiab analysis. Nephrology, https://​doi.​org/​10.​1111/​nep.​13445.CrossRefPubMed
25.
go back to reference Osthus, T., Preljevic, V., Sandvik, L., Leivestad, T., Nordhus, I., Dammen, T., et al. (2012). Mortality and health-related quality of life in prevalent dialysis patients: Comparison between 12-items and 36-items short-form health survey. Health and Quality of Life Outcomes, 10(1), 1.CrossRef Osthus, T., Preljevic, V., Sandvik, L., Leivestad, T., Nordhus, I., Dammen, T., et al. (2012). Mortality and health-related quality of life in prevalent dialysis patients: Comparison between 12-items and 36-items short-form health survey. Health and Quality of Life Outcomes, 10(1), 1.CrossRef
26.
go back to reference Mapes, D., Lopes, A., Satayathum, S., Mccullough, K., Goodkin, D., Locatelli, F., et al. (2003). Health-related quality of life as a predictor of mortality and hospitalization: The dialysis outcomes and practice patterns study (DOPPS). Kidney International, 64, 339–349.CrossRef Mapes, D., Lopes, A., Satayathum, S., Mccullough, K., Goodkin, D., Locatelli, F., et al. (2003). Health-related quality of life as a predictor of mortality and hospitalization: The dialysis outcomes and practice patterns study (DOPPS). Kidney International, 64, 339–349.CrossRef
27.
go back to reference Cavrini, G., Broccoli, S., Puccini, A., & Zoli, M. (2012). EQ-5D as a predictor of mortality and hospitalization in elderly people. Quality of Life Research, 21(2), 269–280.CrossRef Cavrini, G., Broccoli, S., Puccini, A., & Zoli, M. (2012). EQ-5D as a predictor of mortality and hospitalization in elderly people. Quality of Life Research, 21(2), 269–280.CrossRef
31.
go back to reference Norman, R., Church, J., van den Berg, B., & Goodall, S. (2013). Australian health-related quality of life population norms derived from the SF-6D. Australian and New Zealand Journal of Public Health, 37(1), 17–23.CrossRef Norman, R., Church, J., van den Berg, B., & Goodall, S. (2013). Australian health-related quality of life population norms derived from the SF-6D. Australian and New Zealand Journal of Public Health, 37(1), 17–23.CrossRef
Metagegevens
Titel
The impact of progressive chronic kidney disease on health-related quality-of-life: a 12-year community cohort study
Auteurs
Melanie L. R. Wyld
Rachael L. Morton
Phil Clayton
Muh Geot Wong
Meg Jardine
Kevan Polkinghorne
Steve Chadban
Publicatiedatum
01-04-2019
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 8/2019
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-019-02173-1

Andere artikelen Uitgave 8/2019

Quality of Life Research 8/2019 Naar de uitgave